RA Capital Management

Ra Capital Management as of June 30, 2015

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 58 positions in its portfolio as reported in the June 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Axovant Sciences 10.2 $102M 5.0M 20.38
Achillion Pharmaceuticals 8.9 $88M 9.9M 8.86
Sangamo Biosciences (SGMO) 8.1 $80M 7.2M 11.09
Dyax 7.2 $72M 2.7M 26.50
Tg Therapeutics (TGTX) 5.5 $55M 3.3M 16.59
Regulus Therapeutics 4.2 $42M 3.8M 10.96
Coherus Biosciences (CHRS) 4.0 $40M 1.4M 28.90
BioCryst Pharmaceuticals (BCRX) 3.9 $39M 2.6M 14.93
Dicerna Pharmaceuticals 3.4 $34M 2.4M 13.95
Ascendis Pharma A S (ASND) 3.4 $34M 1.9M 17.68
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 2.8 $28M 1.5M 17.84
Ardelyx (ARDX) 2.8 $28M 1.7M 15.97
Proteon Therapeutics 2.7 $27M 1.5M 17.86
Xencor (XNCR) 2.4 $24M 1.1M 21.97
Blueprint Medicines (BPMC) 2.3 $23M 878k 26.49
Bellicum Pharma 2.2 $22M 1.0M 21.27
Medicines Company 2.0 $20M 706k 28.61
Bluebird Bio (BLUE) 1.9 $18M 109k 168.37
Dynavax Technologies (DVAX) 1.8 $18M 766k 23.43
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 1.6 $16M 1.1M 14.02
Novavax 1.6 $16M 1.4M 11.14
Juno Therapeutics 1.5 $15M 280k 53.33
Agenus (AGEN) 1.4 $14M 1.6M 8.63
Omeros Corporation (OMER) 1.4 $14M 749k 17.99
Therapeuticsmd 1.3 $13M 1.7M 7.86
Agile Therapeutics 1.3 $13M 1.5M 8.59
Nivalis Therapeutics 1.1 $12M 757k 15.15
Seres Therapeutics (MCRB) 1.0 $10M 247k 41.50
Alcobra 1.0 $10M 1.5M 6.54
Concert Pharmaceuticals I equity 1.0 $10M 668k 14.89
Tenax Therapeutics 1.0 $9.9M 2.7M 3.69
Sucampo Pharmaceuticals 0.7 $7.4M 450k 16.43
Arca Biopharma 0.7 $6.5M 5.7M 1.15
Auris Med Hldg 0.5 $4.6M 940k 4.86
Aurinia Pharmaceuticals (AUPH) 0.3 $3.5M 1.1M 3.02
Trevena 0.3 $3.3M 528k 6.26
T2 Biosystems 0.2 $2.2M 138k 16.23
Vical Incorporated 0.2 $1.8M 2.6M 0.70
Biota Pharmaceuticals 0.2 $1.7M 808k 2.07
Merrimack Pharmaceuticals In 0.1 $1.4M 116k 12.36
Tesaro 0.1 $1.4M 24k 58.81
Regeneron Pharmaceuticals (REGN) 0.1 $1.2M 2.5k 510.20
Newlink Genetics Corporation 0.1 $1.3M 30k 44.27
Neurocrine Biosciences (NBIX) 0.1 $1.2M 24k 47.75
Alkermes (ALKS) 0.1 $1.2M 19k 64.32
Clovis Oncology 0.1 $1.2M 13k 87.88
Ptc Therapeutics I (PTCT) 0.1 $1.2M 26k 48.14
Incyte Corporation (INCY) 0.1 $1.1M 11k 104.21
Biogen Idec (BIIB) 0.1 $1.1M 2.6k 403.85
ACADIA Pharmaceuticals (ACAD) 0.1 $1.1M 27k 41.87
Agios Pharmaceuticals (AGIO) 0.1 $1.1M 9.9k 111.11
Celgene Corporation 0.1 $1.0M 8.7k 115.75
Amgen (AMGN) 0.1 $906k 5.9k 153.56
Array BioPharma 0.1 $909k 126k 7.21
DURECT Corporation 0.1 $913k 382k 2.39
Wafergen Bio-systems 0.1 $647k 205k 3.15
Keryx Biopharmaceuticals 0.1 $591k 59k 9.98
Puma Biotechnology (PBYI) 0.0 $362k 3.1k 116.77